Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Levofloxacin hemihydrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for One bottle of Levofloxacin eye drops contains 5ml solution with levofloxacin as the active ingredient. For the theoretical volume of one drop equivalent to 0.05ml the amount of drug substance is 0.256mg levofloxacin hemihydrate equivalent to 0.250mg of levofloxacin. Levofloxacin is an antibiotic of the type called fluoroquinolones (sometimes shortened to quinolones). It works by killing some types of bacteria that can cause infections. When levofloxacin is given in eye drops, it is used in children aged 1 year or over and in adults to treat bacterial infections that affect the front surfaces of the eye. One type of infection in this area is called bacterial conjunctivitis, which is an infection of the covering of the front of the eye (conjunctiva). Levofloxacin eye drops is not suitable for treating eye infections that have spread in the deeper layers of the eye coverings or into the fluid within the eyeball. Antibiotic tablets or injections are needed to treat these deeper and more serious infections. Levofloxacin eye drops is not recommended to be used in children aged below 1 year. You must talk to a doctor if you do not feel better or if you feel worse after 5 days.
2. What you need to know before you use Levofloxacin eye drops Do not use Levofloxacin eye drops:
e Levofloxacin eye drops 3. How to use Levofloxacin eye drops 4. Possible side effects 5. How to store Levofloxacin eye drops 6. Contents of the pack and other information
Levofloxacin eye drops Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Levofloxacin eye drops are for ocular use and have to be applied to the outer surface of the eye. For patients above 1-year-old, the recommended dose is as follows: DAYS 1 – 2
3) Place the tip of the bottle close to your eye.
4) Pull the lower eyelid downwards and look up.
5) Press the bottle slightly and let one drop fall into the space between the lower eyelid and the eye.
6) Close your eye and press the inner corner of the eye with your finger for about one minute. Thus you can prevent the eye drop from draining down the tear duct.
7) Wipe off any excess solution from the skin around your eye. If another drop is needed, and when both eyes are to be treated, repeat steps 3 to 6. Replace the cap securely after use. Levofloxacin eye drops should not be injected into the interior part of the eyeball. If you use more Levofloxacin eye drops than you should If you use more Levofloxacin eye drops than you should, flush the eye(s) with water and tell your doctor or pharmacist. If you forget to use Levofloxacin eye drops If you forget to use the eye drops, put in the next dose as soon as you remember. Do not use a double dose to make up for a forgotten dose. If you swallow Levofloxacin eye drops by accident The amount of levofloxacin in the provided bottle is too small to cause side effects. However, if you are concerned, tell your doctor or pharmacist who will advise you on any necessary measures. If you stop using Levofloxacin eye drops earlier than instructed, it may delay the healing process. If you have any further questions on the use of this medicine or wish to stop your treatment, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. About one in ten people have a side effect when using Levofloxacin eye drops. Most of these affect only the eye and may not last very long. If you have any severe or persistent side effects you should stop using Levofloxacin eye drops and seek urgent advice from your doctor. The frequency of possible side effects is defined as following: very common common uncommon rare very rare not known
affects more than 1 user in 10 affects 1 to 10 users in 100 affects 1 to 10 users in 1,000 affects 1 to 10 users in 10,000 affects less than 1 user in 10,000 frequency cannot be estimated from the available data
Very rarely this medicine can cause severe allergic reactions. The following symptoms can occur even after just one dose of Levofloxacin eye drops:
Levofloxacin eye drops Keep this medicine out of the sight and reach of children. Keep the bottle tightly closed. Do not use this medicine after the expiry date which is stated on the bottle. The expiry date refers to the last day of that month. Levofloxacin eye drops are to be used within 28 days after first opening the bottle. Any remaining solution should be returned to your pharmacist for safe disposal. To prevent infections, you must throw away the bottle 28 days after you first opened it, and use a new bottle. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Levofloxacin eye drops contains
1010350-P3.4
Levofloxacin 5mg/ml eye drops solution comes as eye drops containing 5mg/ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Levofloxacin 5mg/ml eye drops solution is levofloxacin hemihydrate.
Medicines with the same active substance, strength and form include: Eyflox 5mg/ml eye drops, solution, Oftaquix 5 mg/ml eye drops, solution, Oftaquix Unit Dose 5 mg/ml eye drops, solution in single dose container. In total there are 4 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Levofloxacin 5mg/ml eye drops solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Levofloxacin 5 mg/ml eye drops are indicated for the topical treatment of bacterial external ocular infections in patients ≥1 year of age caused by levofloxacin susceptible microorganisms (see also sections 4.4 and 5.1).
Levofloxacin 5 mg/ml is indicated in adults, children aged ≥1 to 12 years and adolescents aged 12 to 18 years.
Considerations should be given to official guidance on the appropriate use of antibacterial agents.
Posology
For all patients instil one to two drops in the affected eye(s) every two hours up to 8 times per day while awake for the first two days and then four times daily on days 3 through 5.
If different topical ocular medications are used concomitantly, at least a 15-minute interval is required between instillations.
To prevent contaminating the dropper tip and solution, the dropper tip should not come into contact with the eyelids or surrounding areas.
The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of infection. The usual treatment duration is 5 days.
Safety and efficacy in the treatment of corneal ulcer and ophthalmia neonatorum has not been established.
Levofloxacin 5 mg/ml is not recommended for use in children below age 1 year due to a lack of data on safety and efficacy.
Paediatric population
The posology is the same in adults and children aged ≥ 1 year.
The safety and efficacy of Levofloxacin 5 mg/ml in children aged ≥1 year have been established.
The safety and efficacy of Levofloxacin 5 mg/ml in children < 1 year has not yet been established.
No data are available.
Use in the Elderly
No adjustment of dosage is required.
Method of administration
Ocular use.
Hypersensitivity to the active substance levofloxacin, to other quinolones or to any of the excipients listed in section 6.1, e.g. benzalkonium chloride.
Levofloxacin 5mg/ml eye drops must not be injected sub-conjunctivally. The solution should not be introduced directly into the anterior chamber of the eye.
Systemic fluoroquinolones have been associated with hypersensitivity reactions, even following a single dose. If an allergic reaction to levofloxacin occurs, discontinue the medication.
As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If worsening of infection occurs, or if a clinical improvement is not noted within a reasonable period, discontinue use and institute alternative therapy. Whenever clinical judgement dictates, the patient should be examined with the aid of magnification, such as slit-lamp biomicroscopy, and, where appropriate, fluorescein staining.
Tendon inflammation and rupture may occur with systemic fluoroquinolone therapy including levofloxacin, particularly in older patients and those treated concurrently with corticosteroids. Therefore, caution should be exercised and treatment with Levofloxacin 5mg/ml should be discontinued at the first sign of tendon inflammation (see section 4.8).
Patients with external bacterial ocular infections should not wear contact lenses.
Levofloxacin 5mg/ml eye drops contain benzalkonium chloride, which may cause eye irritation.
Paediatric population
The special warnings and precautions for use are the same for adults and children aged ≥1 year.
Excipients
This medicine contains 0.05 mg benzalkonium chloride in each millilitre of solution, which is equivalent to 0.25mg per 5ml.
Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.
Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
Patients should be monitored in case of prolonged use.
Specific drug interaction studies have not been conducted with Levofloxacin 5mg/ml eye drops. Since maximum plasma concentrations of levofloxacin after ocular administration are at least 1000 times lower than those reported after standard oral doses, interactions mentioned for systemic use are unlikely to be clinically relevant when using Levofloxacin 5 mg/ml eye drops. If different topical ocular medications are used concomitantly, at least a 15-minute interval is required between instillations.
Paediatric population
No interaction studies have been performed.
Pregnancy
There are no adequate data from the use of levofloxacin in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). The potential risk for humans is unknown.
Levofloxacin 5mg/ml eye drops should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Breastfeeding
Levofloxacin is excreted in human milk. However, at therapeutic doses of Levofloxacin no effects on the nursing child are anticipated. Levofloxacin 5mg/ml eye drops should be used during lactation only if the potential benefit justifies any potential risk to the nursing child.
Fertility
Levofloxacin caused no impairment of fertility in rats at exposures considerably in excess of the maximum human exposure after ocular administration (see section 5.3).
Levofloxacin has minor influence on the ability to drive and use machines.
If there are any transient effects on vision, the patient should be advised to wait until this clears before driving or operating machinery.
Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Approximately 10% of patients can be expected to experience adverse reactions.
The reactions are usually graded as mild or moderate, are transient, and are generally restricted to the eye.
As the product contains benzalkonium chloride, contact eczema and/or irritation may be due to the active component or to this preservative.
The following undesirable effects assessed as definitely, probably or possibly related to treatment were reported during clinical trials and post-marketing experience with Levofloxacin 5 mg/ml eye drops.
System organ Class
Frequency
Adverse reaction
Immune system disorders
Rare
Extra-ocular allergic reactions, including skin rash
Very rare, not known (cannot be estimated from the available data)
Anaphylaxis.
Nervous system disorders
Uncommon
Headache
Eye disorders
Common
Ocular burning, decreased vision and mucous strand
Uncommon
Lid matting, chemosis, conjunctival papillary reaction, lid oedema, ocular discomfort, ocular itching, ocular pain, conjunctival injection, conjunctival follicles, ocular dryness, lid erythema, and photophobia
No corneal precipitates were observed in clinical studies.
Respiratory, thoracic and mediastinal disorders
Uncommon
Rhinitis
Very rare, not known (cannot be estimated from the available data)
Laryngeal oedema
Ruptures of the shoulder, hand, Achilles, or other tendons that required surgical repair or resulted in prolonged disability have been reported in patients receiving systemic fluoroquinolones. Studies and post marketing experience with systemic quinolones indicate that a risk of these ruptures may be increased in patients receiving corticosteroids, especially geriatric patients and in tendons under high stress, including Achilles tendon (see section 4.4).
Paediatric population
Frequency, type and severity of adverse reactions in children are expected to be the same as in adults
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme (website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or App Store).
The total amount of levofloxacin in a bottle of eye drops is too small to induce toxic effects after an accidental oral intake. If considered necessary, the patient can be observed clinically and supportive measures can be undertaken. After a local overdose with Levofloxacin 5mg/ml eye drops, the eyes can be flushed with clean (tap) water at room temperature.
Paediatric population
Actions to be taken in case of overdose are the same in adults and in children aged ≥1 year
Ask anything about Levofloxacin 5mg/ml eye drops solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.